Back to company

Organon Denmark ApS: Financial statements 2024

CVR: 41193093

Organon Denmark ApS (CVR 41193093) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 74,127,000 and a net result of DKK 2,428,000 compared with DKK 2,924,000 the year before. That is an increase of 16% compared with the year before. The profit margin was 3.3%. Equity amounted to DKK 27,910,000. The solvency ratio was 67.1%. The company had 15 employees in the financial year.

Revenue
74,127,000 kr.
Gross Profit
22,135,000 kr.
Profit/Loss
2,428,000 kr.
Equity
27,910,000 kr.
Total Assets
41,622,000 kr.
Employees
15

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202474.1 mio.22.1 mio.2.4 mio.27.9 mio.15
202363.9 mio.11.9 mio.2.9 mio.29.5 mio.16
202262 mio.11.9 mio.2.1 mio.26.6 mio.16
202151 mio.8.6 mio.857 t.24.4 mio.13
202049.2 mio.4.4 mio.1.3 mio.22.7 mio.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Organon Denmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Organon Denmark ApS: The 2023 annual report is outJun 28, 2024

Organon Denmark ApS has published its annual report for 2023. Revenue came to DKK 63,900,000, and the net result was DKK 2,924,000.

Isabel Vandenberk joins Organon Denmark ApS as directorApr 1, 2024

As of April 1, 2024, Isabel Vandenberk is registered as director of Organon Denmark ApS.

Torben Dahl steps down as director of Organon Denmark ApSApr 1, 2024

As of April 1, 2024, Torben Dahl has stepped down as director of Organon Denmark ApS.

About Organon Denmark ApS

Organon Denmark ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karl Johan Sundt, Sofia Raquel Paulos Ferreira Alves da Silva and Anne Bitzer. The company is owned by OBS Human Health Holding B.V.. In 2025, the company reported revenue of DKK 61,554,000 and a net result of DKK 3,139,000 compared with DKK 2,428,000 the year before. Equity amounted to DKK 31,049,000.

Other financial years